UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$155M |
| 2 |
Wells Fargo
WFC
|
+$134M |
| 3 |
Biogen
BIIB
|
+$121M |
| 4 |
Alibaba
BABA
|
+$108M |
| 5 |
Delta Air Lines
DAL
|
+$107M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Scotiabank
BNS
|
+$255M |
| 2 |
Chevron
CVX
|
+$220M |
| 3 |
Bank of Montreal
BMO
|
+$192M |
| 4 |
Canadian Imperial Bank of Commerce
CM
|
+$191M |
| 5 |
Enbridge
ENB
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.93% |
| 2 | Financials | 14.16% |
| 3 | Healthcare | 13.87% |
| 4 | Consumer Discretionary | 11.78% |
| 5 | Industrials | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCG
701
DELISTED
Scana
SCG
| $21.7M | 0.02% |
557,558
+9,361
| +2% | +$359K |
|
|
SBNY
702
DELISTED
Signature Bank
SBNY
| $21.7M | 0.02% |
188,748
+8,984
| +5% | +$1.06M |
|
|
ACC
703
DELISTED
American Campus Communities, Inc.
ACC
| $21.6M | 0.02% |
525,152
+40,099
| +8% | +$1.68M |
|
|
QTS
704
DELISTED
QTS REALTY TRUST, INC.
QTS
| $21.6M | 0.02% |
505,650
+361,298
| +250% | +$15.8M |
|
705
Live Nation Entertainment
LYV
$42.8B
| $21.6M | 0.02% |
395,828
+6,686
| +2% | +$339K |
|
|
AYX
706
DELISTED
Alteryx Inc
AYX
| $21.4M | 0.02% |
+374,725
| New | +$19.1M |
|
707
Ligand Pharmaceuticals
LGND
$5.99B
| $21.4M | 0.02% |
125,113
-43,834
| -26% | -$6.61M |
|
708
Omega Healthcare
OHI
$14.7B
| $21.3M | 0.02% |
648,686
+30,278
| +5% | +$964K |
|
709
8x8 Inc
EGHT
$335M
| $21.2M | 0.02% |
998,641
+20,046
| +2% | +$437K |
|
710
Sabre
SABR
$874M
| $21.1M | 0.02% |
810,783
+80,043
| +11% | +$2.05M |
|
711
Roku
ROKU
$22.5B
| $21.1M | 0.02% |
+289,360
| New | +$16.6M |
|
712
Grand Canyon Education
LOPE
$3.92B
| $21M | 0.02% |
185,770
+8,842
| +5% | +$1.03M |
|
713
Coherus Oncology
CHRS
$210M
| $20.8M | 0.02% |
1,261,837
-51,136
| -4% | -$906K |
|
714
Equinor
EQNR
$92.9B
| $20.8M | 0.02% |
737,104
-212
| -0% | -$5.57K |
|
|
HPP
715
Hudson Pacific Properties
HPP
$802M
| $20.7M | 0.02% |
90,162
+4,942
| +6% | +$1.16M |
|
716
American Airlines Group
AAL
$10.5B
| $20.6M | 0.02% |
498,020
-14,392
| -3% | -$562K |
|
717
iShares Core US Aggregate Bond ETF
AGG
$138B
| $20.5M | 0.02% |
+194,487
| New | +$20.6M |
|
718
Schwab US Large- Cap ETF
SCHX
$74.2B
| $20.4M | 0.02% |
1,759,842
-25,608
| -1% | -$291K |
|
719
Mattel
MAT
$4.24B
| $20.4M | 0.02% |
1,298,154
+3,243
| +0.3% | +$51.9K |
|
720
Neurocrine Biosciences
NBIX
$16.6B
| $20.2M | 0.02% |
164,245
-198,975
| -55% | -$22.6M |
|
721
Middleby
MIDD
$6.08B
| $20.2M | 0.02% |
155,964
+4,346
| +3% | +$496K |
|
722
Evolent Health
EVH
$424M
| $20M | 0.01% |
705,674
+29,255
| +4% | +$698K |
|
723
United Therapeutics
UTHR
$22.8B
| $20M | 0.01% |
156,676
+13,983
| +10% | +$1.73M |
|
|
WMGI
724
DELISTED
Wright Medical Group Inc
WMGI
| $19.9M | 0.01% |
685,614
+19,604
| +3% | +$528K |
|
725
Crown Holdings
CCK
$13.1B
| $19.8M | 0.01% |
412,197
+6,812
| +2% | +$303K |
|
Similar funds
UBS AM's Q3 2018 Portfolio in Review
As of Q3 2018, UBS AM held 2,869 positions worth $135B, up 3.1% from $130B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS AM's Q3 2018 filing shows 86 new, 1,174 increased, 804 reduced and 106 closed positions. Its largest new stake was Athene Holding Ltd. Class A Common Shares: 1,079,023 shares worth $55.7M. The largest sale was Scotiabank, an estimated $255M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
- UBS AM's largest Q3 2018 buy was Athene Holding Ltd. Class A Common Shares: 1,079,023 shares worth $55.7M.
- UBS AM added most to Allergan plc in Q3 2018, an estimated $155M increase.
- UBS AM's biggest Q3 2018 reduction was Scotiabank, cutting an estimated $255M.
- UBS AM fully exited BCE in Q3 2018, selling an estimated $35M.
- UBS AM's ten largest holdings make up 18% of its $135B portfolio in Q3 2018.
- UBS AM opened 86 new positions and closed 106 in Q3 2018.
- UBS AM's portfolio value rose 3.1% quarter-over-quarter to $135B.
Based on UBS AM's 13F filing for Q3 2018, filed 14 Nov 2018.